An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
Cancer Medicine · 2024
DOI: 10.1002/cam4.6908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Linyong Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical Universit…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Single-Cell Analysis, Transcriptome, Immunotherapy. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Provincial Clinical Medical Research Center for First Aid and Rehabilitation in Orthopaedic Trauma, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Background
Currently, many stemness‐related signatures have been developed for gastric cancer (GC) to predict prognosis and immunotherapy outcomes. However, due to batch effects, these signatures cannot accurately analyze patients one by one, rendering them impractical in real clinical scenarios. Therefore, we aimed to develop an individualized and clinically applicable signature based on GC stemness.
Methods
Malignant epithelial cells from single‐cell RNA‐Seq data of GC were used to identify stemness‐related signature genes based on the CytoTRACE score. Using two bulk tissue datasets as training data, the enrichment scores of the signature genes were applied to classify samples into two subtypes. Then, using the identified subtypes as criteria, we developed an individualized stemness‐related signature based on the within‐sample relative expression orderings of genes.
Results
We identified 175 stemness‐related signature genes, which exhibited significantly higher AUCell scores in poorly differentiated GCs compared to differentiated GCs. In training datasets, GC samples were classified into two subtypes with significantly different survival times and genomic characteristics. Utilizing the two subtypes, an individualized signature was constructed containing 47 gene pairs. In four independent testing datasets, GC samples classified as high risk exhibited significantly shorter survival times, higher infiltration of M2 macrophages, and lower immune responses compared to low‐risk samples. Moreover, the potential therapeutic targets and corresponding drugs were identified for the high‐risk group, such as CD248 targeted by ontuxizumab.
Conclusions
We developed an individualized stemness‐related signature, which can accurately predict the prognosis and efficacy of immunotherapy for each GC sample.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
- Department of Gastrointestinal Surgery, Fuzhou Second Hospital, Fuzhou, China.
- Key Laboratory of Ministry of Education for Gastrointestinal Cancer, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
ORCID-Profile: Haidan Yan
Förderung
- Fujian Provincial Clinical Medical Research Center for First Aid and Rehabilitation in Orthopaedic Trauma
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zheng, L., Chen, J., Ye, W., Fan, Q., Chen, H., & Yan, H. (2024). An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes. Cancer Medicine. https://doi.org/10.1002/cam4.6908
Vancouver
Zheng L, Chen J, Ye W, Fan Q, Chen H, Yan H. An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes. Cancer Medicine. 2024. doi:10.1002/cam4.6908
BibTeX
@article{Zheng2024,
author = {Zheng, Linyong and Chen, Jingyan and Ye, Wenhai and Fan, Qi and Chen, Haifeng and Yan, Haidan},
title = {An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6908}
}
EUVIMED